Literature DB >> 2354995

Corticosterone regulates calbindin-D28k mRNA and protein levels in rat hippocampus.

A M Iacopino1, S Christakos.   

Abstract

Corticosterone was administered to normal and bilaterally adrenalectomized rats (250-300 g), and hormonal regulation of brain calbindin-D28k (CaBP28k) levels was investigated by radioimmunoassay for CaBP28k protein and by slot and Northern blot analyses for CaBP28k mRNA. The specificity of the changes observed in CaBP28k mRNA levels was tested by reprobing blots with calmodulin and B-actin cDNAs. Rats were either adrenalectomized, adrenalectomized treated with corticosterone, intact, or intact treated with corticosterone. Chronic corticosterone administration (subcutaneous injection for 7 days, 10 mg/day) to normal intact rats significantly increased levels of CaBP28k immunoreactivity (43%) and mRNA (125%) in the hippocampus. Adrenalectomy (animals were killed 7 days after adrenalectomy) produced a significant decrease in hippocampal CaBP28k immunoreactivity (85%) and mRNA (80%) compared with intact controls. Immunocytochemical analysis of tissue sections inducated a marked depletion of CaBP28k immunoreactivity in the dentate gyrus of the hippocampus 2 weeks after adrenalectomy. When adrenalectomized rats were treated with corticosterone (10 mg/day for 7 days), CaBP28k protein and mRNA levels in hippocampus were restored to levels observed in intact controls. No changes in CaBP28k protein and mRNA in kidney, cerebellum, striatum, or cerebral cortex were noted in adrenalectomized rats or in intact rats treated with corticosterone when compared with controls, indicating the specificity of the effect on CaBP28k for the hippocampus. These studies present the first evidence of a regulator of CaBP28k gene expression in the brain.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2354995

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Diffusion and extrusion shape standing calcium gradients during ongoing parallel fiber activity in dendrites of Purkinje neurons.

Authors:  Hartmut Schmidt; Oliver Arendt; Jens Eilers
Journal:  Cerebellum       Date:  2012-09       Impact factor: 3.847

2.  Androgen mitigates axotomy-induced decreases in calbindin expression in motor neurons.

Authors:  J Pérez; D B Kelley
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

Review 3.  Calcium-binding proteins: selective markers of nerve cells.

Authors:  C Andressen; I Blümcke; M R Celio
Journal:  Cell Tissue Res       Date:  1993-02       Impact factor: 5.249

Review 4.  Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system.

Authors:  J P Herman
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

Review 5.  Glucocorticoids and the ageing hippocampus.

Authors:  C Hibberd; J L Yau; J R Seckl
Journal:  J Anat       Date:  2000-11       Impact factor: 2.610

6.  Calbindin-D28K dynamically controls TRPV5-mediated Ca2+ transport.

Authors:  Tim T Lambers; Frank Mahieu; Elena Oancea; Louis Hoofd; Frank de Lange; Arjen R Mensenkamp; Thomas Voets; Bernd Nilius; David E Clapham; Joost G Hoenderop; René J Bindels
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

7.  Resveratrol Directly Controls the Activity of Neuronal Ryanodine Receptors at the Single-Channel Level.

Authors:  Jacob G Kraus; Peter Koulen
Journal:  Mol Neurobiol       Date:  2019-08-02       Impact factor: 5.590

8.  Glucocorticoids regulate protein synthesis in hippocampal slices under mild heat shock conditions.

Authors:  C S Barr; L A Dokas
Journal:  Endocrine       Date:  1998-04       Impact factor: 3.925

Review 9.  Neuronal calcium signaling: function and dysfunction.

Authors:  Marisa Brini; Tito Calì; Denis Ottolini; Ernesto Carafoli
Journal:  Cell Mol Life Sci       Date:  2014-01-19       Impact factor: 9.261

10.  Calcium signaling in neurodegeneration.

Authors:  Philippe Marambaud; Ute Dreses-Werringloer; Valérie Vingtdeux
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.